DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Epizyme (NASDAQ: EPZM)



company name or ticker

Is The Healthcare Sector Pulling Back Or Crashing?

Epizyme Heads Back to Wall Street, Plans $140M Raise

J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech

Epizyme's CEO Presents at 32nd Annual JPMorgan Healthcare Conference (Transcript)

Was Celgene Corporation's Preview Really $2 Billion Worth of Disappointment?

Celgene disappointed investors with a Q4 earnings miss and lower-than-expected 2014 earnings projections. But was the news really that bad?

3 Stocks Rising on Unusual Volume

Celgene's Bet on Epizyme Pays Off

Celgene and Epizyme got a big boost this week when Epizyme's EPZ-5676 met an important milestone.

This Week in Biotech: Putting On a Clinic

In part one of This Week in Biotech we're looking at four encouraging clinical trials, including a company that gained 545%, as well as an announced collaboration and a buyout.

3 Humongous Health-Care Stocks This Week

Intercept Pharmaceuticals, Neurocrine Biosciences, and Epizyme achieve stunning gains in a great week for health-care investors.

Epizyme Up on Milestone Payments - Analyst Blog

Epizyme Up on Milestone Payments - Analyst Blog